Search - tctmd.com

Displaying 241 - 260 of 1120

Sort: Relevancy | Date

Presentation TCT 2016

Case Introduction: An 87 Year Old Woman With Recurrent Dyspnea 7 Years After TAVR

Presenter: Nick Curzen, Michael Mahmoudi

October 31, 2016

Presentation TCT 2016

Ventricular Reshaping: From CorCap to VenTouch

Presenter: Ted Feldman, Scott Lim

October 31, 2016

Presentation TCT 2016

Tricuspid Repair with the Trialign System

Presenter: Eric Horlick, Josep Rodés-Cabau, Charles J. Davidson

October 31, 2016

Presentation TCT 2016

Update on Artificial Chords II: Harpoon

Presenter: Ted Feldman, Scott Lim, James S. Gammie

October 31, 2016

Presentation TCT 2016

Flash Debate: Counterpoint In Lower Risk Patients, A Thoughtful Hybrid Strategy Is Preferred!

Presenter: Raj Makkar, Lars Sondergaard, Stephen J.D. Brecker

October 31, 2016

Presentation TCT 2016

Update on Artificial Chords I: Neochord

Presenter: Ted Feldman, Scott Lim, Joerg Seeburger

October 31, 2016

Presentation TCT 2016

Flash Debate: Point In Lower Risk Patients, the Minimalist Strategy Should Be the Default Approach!

Presenter: Raj Makkar, Lars Sondergaard, Antonio Colombo

October 31, 2016

Presentation TCT 2016

TAVR for Intermediate-Risk and Low-Risk Patients: Review of the Literature

Presenter: Niall T. Mulvihill, Michael Mahmoudi

October 31, 2016

Presentation TCT 2016

Indirect Annuloplasty via the Coronary Sinus II: Mitral Cerclage

Presenter: Ted Feldman, Scott Lim, Robert J. Lederman

October 31, 2016

Presentation TCT 2016

Transcatheter Valve Repair Solution - When, After the Mitral Valve, the Tricuspid Should Be Treated

Presenter: Eric Horlick, Josep Rodés-Cabau, Maurizio Taramasso

October 31, 2016

Presentation TCT 2016

Controversy 4. Will the Minimalist Strategy Dominate TAVR in the Future: Supportive Clinical and Economic Data

Presenter: Raj Makkar, Lars Sondergaard, Ganesh Manoharan

October 31, 2016

Presentation TCT 2016

Indirect Annuloplasty via the Coronary Sinus II: MVRx

Presenter: Ted Feldman, Scott Lim, David Hildick-Smith

October 31, 2016

Presentation TCT 2016

Debate: Should All Low-Risk Patients With Severe Aortic Stenosis Who are Suitable Be Allowed to Choose TAVR Rather than Surgical AVR, Without Further Trial Evidence? Con Position

Presenter: Niall T. Mulvihill, Hellmuth Weich

October 31, 2016

Presentation TCT 2016

Indirect Annuloplasty via the Coronary Sinus I: Updated Carillon Results and Future Plans

Presenter: Ted Feldman, Scott Lim, Samir R. Kapadia

October 31, 2016

Presentation TCT 2016

Late (>5 years) Clinical and Echo Outcomes After TAVR II: The Vancouver Experience

Presenter: Raj Makkar, Lars Sondergaard, John G. Webb

October 31, 2016

Presentation TCT 2016

Debate: Should All Low-Risk Patients With Severe Aortic Stenosis Who are Suitable Be Allowed to Choose TAVR Rather than Surgical AVR, Without Further Trial Evidence? Pro Position

Presenter: Niall T. Mulvihill, Antoniette Neylon

October 31, 2016

Presentation TCT 2016

Trialign for Functional TR: Early US Experience

Presenter: Eric Horlick, Josep Rodés-Cabau, Charles J. Davidson

October 31, 2016

Presentation TCT 2016

Introduction: TAVR in Intermediate-Risk and Low-Risk With Severe Aortic Stenosis

Presenter: Niall T. Mulvihill

October 31, 2016

Presentation TCT 2016

Congenital Heart Disease: PFO, ASD, PDA and Coarctation

Presenter: Harsimran Sachdeva Singh, John P. Breinholt

October 31, 2016

Presentation TCT 2016

Late (>5 years) Clinical and Echo Outcomes After TAVR I: The Rouen Experience

Presenter: Raj Makkar, Lars Sondergaard, Helene Eltchaninoff

October 31, 2016

Advertisement

Case Introduction: An 87 Year Old Woman With Recurrent Dyspnea 7 Years After TAVR

Ventricular Reshaping: From CorCap to VenTouch

Tricuspid Repair with the Trialign System

Update on Artificial Chords II: Harpoon

Flash Debate: Counterpoint In Lower Risk Patients, A Thoughtful Hybrid Strategy Is Preferred!

Update on Artificial Chords I: Neochord

Flash Debate: Point In Lower Risk Patients, the Minimalist Strategy Should Be the Default Approach!

TAVR for Intermediate-Risk and Low-Risk Patients: Review of the Literature

Indirect Annuloplasty via the Coronary Sinus II: Mitral Cerclage

Transcatheter Valve Repair Solution - When, After the Mitral Valve, the Tricuspid Should Be Treated

Controversy 4. Will the Minimalist Strategy Dominate TAVR in the Future: Supportive Clinical and Economic Data

Indirect Annuloplasty via the Coronary Sinus II: MVRx

Debate: Should All Low-Risk Patients With Severe Aortic Stenosis Who are Suitable Be Allowed to Choose TAVR Rather than Surgical AVR, Without Further Trial Evidence? Con Position

Indirect Annuloplasty via the Coronary Sinus I: Updated Carillon Results and Future Plans

Late (>5 years) Clinical and Echo Outcomes After TAVR II: The Vancouver Experience

Debate: Should All Low-Risk Patients With Severe Aortic Stenosis Who are Suitable Be Allowed to Choose TAVR Rather than Surgical AVR, Without Further Trial Evidence? Pro Position

Trialign for Functional TR: Early US Experience

Introduction: TAVR in Intermediate-Risk and Low-Risk With Severe Aortic Stenosis

Congenital Heart Disease: PFO, ASD, PDA and Coarctation

Late (>5 years) Clinical and Echo Outcomes After TAVR I: The Rouen Experience

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content